-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Insulet, Raises Price Target to $180

Benzinga·11/05/2026 19:29:55
Listen to the news
RBC Capital analyst Kendall Au maintains Insulet (NASDAQ:PODD) with a Outperform and raises the price target from $160 to $180.